Graham McGlashan of Marks & Clerk LLP discusses the impact of tech on healthcare systems, providing possibilities for more self-management and preventa
A specialist British pharmaceutical wholesaler and distributor CHAPPER healthcare, will be exhibiting at the 9th World Orphan Drug Congress to help raise awareness of speciality medicines and the c
The US Food and Drug Administration (FDA) has approved Merck & Co’s Keytruda plus chemotherapy as a first-line treatment for non-small cell lung cancer (NSCLC).
A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.
